Target intelligence / Profile preview

B-cell receptor specific for HIV-1 Envelope protein (HIV-1 Env-specific BCR)

Target
HIV-1 Env-specific BCR
Molecular classification
Receptor, Immunoglobulin family
01

Overview

The B-cell receptor (BCR) specific for the HIV-1 Envelope (Env) protein is the primary target for modern germline-targeting vaccine strategies aimed at preventing HIV-1 infection. These receptors are membrane-bound immunoglobulins on B cells that recognize the HIV-1 Env trimer, the sole viral surface protein responsible for host cell entry (Haynes et al., Nature Reviews Immunology, 2023). Because HIV-1 evolves rapidly, vaccines must stimulate B cells to produce broadly neutralizing antibodies (bNAbs) that can recognize conserved regions of the Env protein across diverse viral strains. Current therapeutic approaches involve using highly engineered protein or mRNA-based immunogens, such as eOD-GT8 60mer, to selectively engage rare precursor B cells expressing specific BCR sequences (Jardine et al., Science, 2013). By guiding the maturation of these B cells through sequential immunization, researchers hope to elicit protective immunity that the natural immune response typically fails to generate during infection. This target is central to the reductionist vaccine design approach, which focuses on specific epitopes like the CD4 binding site or the V3-glycan patch (Sok & Burton, Nature Reviews Immunology, 2018). Successful engagement of these BCRs is monitored through high-sensitivity flow cytometry and single-cell sequencing to track the expansion of specific B-cell lineages (Leggat et al., Science, 2022). Ultimately, the goal is to induce a durable and broad antibody response capable of neutralizing the vast majority of global HIV-1 variants.

Other names
HIV-1 Env-specific B-cell receptorAnti-HIV-1 Env BCRGermline BCR for broadly neutralizing antibodiesHIV-1 envelope-binding B-cell receptorHIV-1 Env-reactive BCR
02

Mechanism of action

Binding of engineered immunogens to specific germline or intermediate B-cell receptors to trigger B-cell activation, clonal expansion, and somatic hypermutation toward the production of broadly neutralizing antibodies (Jardine et al., Science, 2016).

03

Biological functions

Immune responseAntigen recognitionB-cell activationAntibody productionAffinity maturation
04

Disease associations

HIV-1 infectionInfection
05

Safety considerations

Induction of autoantibodiesImmunodominance of non-neutralizing epitopesPotential for vaccine-induced enhancement of infectionOff-target B-cell activation (Haynes et al., Nature Reviews Immunology, 2023)
06

Interacting drugs

eOD-GT8 60mer

4 more in the full profile.

07

Biomarkers

Env-specific B-cell frequencyBroadly neutralizing antibody (bNAb) titersBCR repertoire sequencingVRC01-class precursor frequency (Leggat et al., Science, 2022)

Beyond the preview

Go deeper on B-cell receptor specific for HIV-1 Envelope protein (HIV-1 Env-specific BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor specific for HIV-1 Envelope protein (HIV-1 Env-specific BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call